This role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells

被引:27
作者
Abdullah, N [1 ]
Greenman, J [1 ]
Pimenidou, A [1 ]
Topping, KP [1 ]
Monson, JRT [1 ]
机构
[1] Univ Hull, Med Res Lab, Acad Surg Unit, Kingston Upon Hull HU6 7RX, N Humberside, England
关键词
humanised antibodies; cellular cytotoxicity; colorectal tumours;
D O I
10.1007/s002620050600
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Monocytes and natural killer (NK) cells are known to be important effector cell populations in mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Purified monocyte and NK effector cell populations, from normal and colorectal cancer (CRC) patients,,together with a number of murine (17-1A and 323/A3) and their chimaeric (c17-1A) or humanised (3622W94) equivalents, and chimaeric (c) SF25 were compared for their ability to mediate ADCC of colorectal tumour cells. The chimaeric and humanised antibodies were significantly better at mediating tumour lysis than their murine equivalents with all-effector populations. When effector cells from CRC patients were used the cSF25 antibody was significantly better than 3622W94 (P < 0.02) which, in turn, was significantly better than c17-1A (P < 0.03). Depletion of NK cells produced: a decrease in specific tumour lysis with all antibodies. In addition a higher rate of NK cell death was observed in CRC patients during the assay than in normal controls. The chimaeric and humanised antibodies stained a similar percentage of the HT-29 target cells (>80%), but 3622W94 bound to significantly more cells from primary tumour biopsies than cSF-25 (P = 0.001). Together, the results suggest that NK cells are the most important effector cell type mediating ADCC in vitro, that there is some impairment of NK function in CRC patients, and that cSF25 is the most potent antibody. For use in vivo the anti-Ep-CAM antibody 3622W94 would appear to be the most suitable reagent for further study.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 31 条
[1]
CLINICAL PERSPECTIVE OF HUMAN COLORECTAL-CANCER METASTASIS [J].
AUGUST, DA ;
OTTOW, RT ;
SUGARBAKER, PH .
CANCER AND METASTASIS REVIEWS, 1984, 3 (04) :303-324
[2]
ANALYSIS OF THE RELATIONSHIP BETWEEN STAGE OF DIFFERENTIATION AND NK LAK SUSCEPTIBILITY OF COLON-CARCINOMA CELLS [J].
BLOTTIERE, HM ;
ZENNADI, R ;
GREGOIRE, M ;
AILLET, G ;
DENIS, MG ;
MEFLAH, K ;
LEPENDU, J .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :409-417
[3]
BRITTENDEN J, 1991, CANCER, V77, P1226
[4]
CALVETE JA, 1994, CANCER RES, V54, P4684
[5]
BLOCKADE OF CLEARANCE OF IMMUNE-COMPLEXES BY AN ANTI-FC-GAMMA-RECEPTOR MONOCLONAL-ANTIBODY [J].
CLARKSON, SB ;
KIMBERLY, RP ;
VALINSKY, JE ;
WITMER, MD ;
BUSSEL, JB ;
NACHMAN, RL ;
UNKELESS, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) :474-489
[6]
Colombo MP, 1996, CANCER RES, V56, P2531
[7]
Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone [J].
Davis, TA ;
Maloney, DG ;
Czerwinski, DK ;
Liles, TM ;
Levy, R .
BLOOD, 1998, 92 (04) :1184-1190
[8]
Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies [J].
Deo, YM ;
Graziano, RF ;
Repp, R ;
vandeWinkel, JGJ .
IMMUNOLOGY TODAY, 1997, 18 (03) :127-135
[9]
FAGERBERG J, 1995, CANCER RES, V55, P1824
[10]
HIGH-AFFINITY IGE RECEPTOR ON EOSINOPHILS IS INVOLVED IN DEFENSE AGAINST PARASITES [J].
GOUNNI, AS ;
LAMKHIOUED, B ;
OCHIAI, K ;
TANAKA, Y ;
DELAPORTE, E ;
CAPRON, A ;
KINET, JP ;
CAPRON, M .
NATURE, 1994, 367 (6459) :183-186